SOLARIS THERAPEUTICS
SOLARIS THERAPEUTICS
Industry:
Biotechnology
Address:
Doylestown, Pennsylvania, United States
Country:
United States
Status:
Active
Total Funding:
0
Similar Organizations
Adriacell
Anti-tumor therapeutics
ImCure Therapeutics
ImCure Therapeutics
Investors List
BioAdvance
BioAdvance investment in Seed Round - Solaris Therapeutics
BioAdvance
BioAdvance investment in Seed Round - Solaris Therapeutics
BioAdvance
BioAdvance investment in Seed Round - Solaris Therapeutics
BioAdvance
BioAdvance investment in Seed Round - Solaris Therapeutics
More informations about "Solaris Therapeutics"
Management | solaris
Before stepping into the CEO role, Shalin served as COO and Head of Regulatory Affairs at Solaris Pharma, where he oversaw a broad range of critical functions, including Portfolio Strategy, Business Development & Licensing, …See details»
Solaris Pharma | pharmaceuticals
Mar 20, 2017 Solaris Pharma Corporation is a leading specialty pharmaceutical company committed to the identifying, developing and marketing of high-quality, complex, generic and specialty pharmaceutical products.See details»
Solaris Therapeutics, Inc.: Drug pipelines, Patents, Clinical trials ...
Explore Solaris Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, .See details»
Solaris Therapeutics | Doylestown, PA, USA Startup - Gust
Find investment information and connect with Solaris Therapeutics, a Doylestown, PA, USA based Biotechnology startup.See details»
S&P Global Ratings
Oct 4, 2024 TORONTO (S&P Global Ratings) Oct. 3, 2024--S&P Global Ratings today took the rating actions listed above. Our rating on Solaris is underpinned by the critical life-extending …See details»
From the Corner Office: Michael Artinger, PhD – CEO of Solaris …
Jul 28, 2023 I have been very fortunate to have had a varied and diverse career accelerating the development of life science innovation, including therapeutics, vaccines, medical devices, …See details»
Solaris Therapeutics INC | (917) 710-5590 - AllBiz
Business Description Solaris Therapeutics INC is located in Doylestown, Pennsylvania, and was founded in 2008. This business is working in the following industry: Pharmacies and drug …See details»
Global Solutions — Solaris Research Institute
Powered by extensive experience and expertise of the team Solaris is well positioned to support biotech and pharma looking to conduct global clinical trials. Lab-to-patient Complete, …See details»
Dr Lakshmi Raghavan – Spektrum Capital
US based, Dr. Raghavan is a successful entrepreneur with more than 25 years of technical and business development expertise. Lakshmi Raghavan, PhD is currently the Founder and President of Solaris Pharma Corporation, leading …See details»
Home - Solaris Health Partners
Solaris Health is a leading national healthcare platform committed to enhancing access to specialty healthcare and continually improving patient outcomes.See details»
Solaris Research Institute
At Solaris Research Institute, our mission is to lead the way in research excellence in the pain and spine specialty through our specialized Contract Research Organisation (CRO) services …See details»
Scott Sellinger, MD, FACS - Solaris Health Partners
Dr. Scott Sellinger is Advisor, Advanced Prostate Cancer Therapeutics for Solaris Health. a national platform committed to enhancing access to specialty healthcare.See details»
Solaris Pharmaceuticals Inc Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Solaris Pharmaceuticals Inc of Surrey, BC. Get the latest business insights from Dun & Bradstreet.See details»
Solaris Vaccines - Crunchbase Company Profile & Funding
Who are Solaris Vaccines's competitors? Alternatives and possible competitors to Solaris Vaccines may include Vigil Neuroscience, Cedilla Therapeutics, and Flightpath Biosciences.See details»
Solaris SRB on LinkedIn: Congratulations Plakous Therapeutics for …
Congratulations Plakous Therapeutics for your fantastic presentations at the annual American Association of Tissue Banks meeting! Solaris is proud to be a…See details»
Solaris Therapeutics - Funding, Financials, Valuation & Investors
Feb 10, 2012 Solaris Therapeutics has raised 4 rounds. Their latest funding was raised on Feb 10, 2012 from a Seed round. Solaris Therapeutics is funded by BioAdvance.See details»
TEV-‘749 Demonstrates No Incidence Of Postinjection …
Sep 24, 2024 Notably, the SOLARIS (period 1) and phase 1 safety results of TEV-‘749 demonstrated no incidence of postinjection delirium/sedation syndrome (PDSS), or the sudden …See details»
EstroGel® (estradiol) – First-time generic - OptumRx
April 25, 2024 - Solaris launched an AB-rated generic version of Ascend Therapeutics’ EstroGel (estradiol) 0.06% transdermal gel.See details»
Viralgen Joins Orphan Therapeutics Accelerator Clinical …
8 hours ago The Orphan Therapeutics Accelerator (OTXL) is a patient-centered non-profit biotech focused on obtaining and reinitiating development of promising "shelved" clinical-stage …See details»
Teva Presents Latest Schizophrenia Treatment Research, Including …
Nov 1, 2024 SOLARIS is a multinational, multicenter, randomized, double-blind, parallel-group, placebo-controlled study to evaluate the efficacy, safety and tolerability of olanzapine …See details»